Warning: The NCBI web site requires JavaScript to function. more...
Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
Granato AM, Nanni O, Falcini F, Folli S, Mosconi G, De Paola F, Medri L, Amadori D, Volpi A.
Breast Cancer Res. 2004;6(1):R38-45. Epub 2003 Nov 25.
Related citations
Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
Bairey O, Zimra Y, Shaklai M, Rabizadeh E.
Br J Haematol. 2001 May;113(2):400-6.
Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
Wallner G, Ciechański A, Dabrowski A, Kozłowski M, Roliński J, Laudański J, Cwik G.
Folia Histochem Cytobiol. 2001;39 Suppl 2:122-3.
Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma.
Graeven U, Andre N, Achilles E, Zornig C, Schmiegel W.
J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81.
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT.
Br J Cancer. 1997;76(2):238-43.
Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
Clin Cancer Res. 2001 Mar;7(3):538-43.
[Expression of bFGF and VEGF in acute leukemia and its effects on HL-60 cell growth].
Zhang WP, Chun XQ, Zhang YQ, Liang R, Li YH, Gao GX, Zhu HF.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):91-4. Chinese.
Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Moriyama S, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
Surg Today. 2001;31(11):1038-40.
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.
Linderholm BK, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, Bergh J, Grankvist K, Henriksson R.
Clin Breast Cancer. 2003 Dec;4(5):340-7.
Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
Waltham M, Burnand KG, Collins M, Smith A.
J Vasc Surg. 2000 Nov;32(5):988-96.
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
Curigliano G, Petit JY, Bertolini F, Colleoni M, Peruzzotti G, de Braud F, Gandini S, Giraldo A, Martella S, Orlando L, Munzone E, Pietri E, Luini A, Goldhirsch A.
Breast Cancer Res Treat. 2005 Sep;93(1):35-40.
Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
Linder C, Linder S, Munck-Wikland E, Strander H.
Anticancer Res. 1998 May-Jun;18(3B):2063-8.
Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival.
Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, Harris AL.
Ann Oncol. 1999 Jun;10(6):707-13.
Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P, Eming S, Nashan D, Krieg T, Mauch C.
Br J Dermatol. 2007 Apr;156(4):653-8. Epub 2007 Jan 30.
High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer.
Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P, Rosato E, Sauter E.
Cancer J. 2002 Jul-Aug;8(4):303-10.
[Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L, Andrýs C, Krejsek J, Belada DZ, Zák P, Siroký O, Malý J.
Vnitr Lek. 2007 Nov;53(11):1171-6. Czech.
[Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck].
Dietz A, Rudat V, Vanselow B, Conradt C, Möhler T.
HNO. 1999 Aug;47(8):695-701. German.
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
Cancer. 2002 Nov 1;95(9):1923-30.
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
Sezer O, Jakob C, Eucker J, Niemöller K, Gatz F, Wernecke K, Possinger K.
Eur J Haematol. 2001 Feb;66(2):83-8.
Serum evaluation of basic FGF in breast cancer patients.
Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C.
Anticancer Res. 1995 Nov-Dec;15(6B):2675-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on